This disruptive expansion of the business model by digital technologies requires a radically new outlook on product development, collaboration and research. Yet digital innovations can't just start on a green field in the pharmaceutical industry. To gain strategic advantages, such innovations must be linked with critical processes, structures and regulatory requirements of the industry.
For the CIO in the pharmaceutical industry, this requirement becomes a complex task. He/she must be equally at home in the old world and in the new. There aren't many people capable of managing this balancing act. But HealthCorp Partners will find them.
The development of highly effective, increasingly individualised therapies holds enormous potential and opportunities both for patients and for the pharmaceutical industry. That said, the personalisation of medicine involves huge costs as well as legal and regulatory requirements e.g. the AMNOG (Pharmaceuticals Market Reorganisation Act) or reimbursement which further contribute to market and competitive pressure.
Against this background, digital technology and artificial intelligence are becoming increasingly important, both in the development of drugs and in demonstrating their efficacy.
The pharmaceutical industry therefore relies on specialists and executives who not only have the latest technical expertise but broad, interdisciplinary knowledge as well.
They need to be familiar, for example, with integrating data analysis and digital technologies in business models and processes or effectively handling regulatory change. Getting these experts on board has become a critical challenge for the industry.
HealthCorp Partners consultants have extensive operational experience in the pharmaceutical industry.
Our transnational network allows us to foresee personnel requisitions early on and identify the right experts.